Ashwagandha Root Extract
Withania somnifera · Standardised 2.5% to 5.0% Withanolides by HPLC. Low Withaferin-A profile, 100% root source without aerial leaf blending.
How do global pharmaceutical, nutraceutical, and functional brand formulators navigate rigorous regulatory boundaries, eradicate adulteration risks, and guarantee clinical-grade bio-efficacy? Discover the authoritative benchmark for procuring GMP certified botanical extracts—backed by UK-audited analytical precision, end-to-end batch traceability, and comprehensive pharmacopeial documentation.
Nutraspect delivers over 40 standardised plant matrices engineered for high chemical fidelity and uniform bioavailability. Our premier ingredients undergo strict chromatographic verification to satisfy both European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) monographs.
Withania somnifera · Standardised 2.5% to 5.0% Withanolides by HPLC. Low Withaferin-A profile, 100% root source without aerial leaf blending.
Curcuma longa · 95% Total Curcuminoids (Curcumin, DMC, BDMC). Carbon-14 radiocarbon validated natural botanical origin; zero petrochemical synthetic adulteration.
Panax ginseng C.A. Mey. · 5% to 80% Ginsenosides (Rg1, Re, Rb1, Rc, Rd) validated by HPLC. Controlled pesticide residue profile complying with Ph. Eur. 2.8.13.
Silybum marianum · 80% Silymarin (UV) / 30%–50% Silymarin (HPLC - silybin/isosilybin). Low residual ethyl acetate solvent, solvent-free supercritical grade options.
Boswellia serrata · 65% Total Boswellic Acids / up to 30% AKBA (3-O-acetyl-11-keto-beta-boswellic acid) by HPLC. Optimised for clean joint support delivery systems.
Nutraspect supports custom particle sizing (80 to 200 mesh), customized excipient blending (maltodextrin, gum acacia, or carrier-free vacuum dried), and granular variants designed for high-speed direct compression tableting.
Inquire NowGlobal procurement teams encounter unnecessary regulatory roadblocks when suppliers fail to produce defensible analytical data. Nutraspect provides end-to-end technical documentation with every batch lot, ensuring instantaneous compliance clearance by your Quality Assurance and Regulatory Affairs officers.
Assay quantification executed through High-Performance Liquid Chromatography (HPLC) or UHPLC. We guarantee our quantified botanical markers match true reference standards without false UV-Vis inflation.
Rigorous multi-residue screenings via GC-MS/MS and LC-MS/MS detecting 500+ pesticides, ethylene oxide (EtO), 2-chloroethanol, polycyclic aromatic hydrocarbons (PAH4), and heavy metals (Pb, As, Cd, Hg).
Screened strictly under European Pharmacopoeia (Ph. Eur. 5.1.8) Category B and USP <2021/2022> for total viable aerobic count (TAMC), yeasts, moulds, enterobacteria, and pathogens (Salmonella, E. coli).
Processed exclusively using water, non-denatured food-grade ethanol, or supercritical CO2. Residual solvent thresholds strictly comply with ICH Q3C limits and are verified by headspace gas chromatography.
| Botanical Active | Plant Part | Active Marker | Standardisation Profile | Analytical Standard | Target Compendial Compliance |
|---|---|---|---|---|---|
| Ashwagandha (Withania somnifera) | Dried Root | Total Withanolides | 2.5% – 5.0% w/w | HPLC (External Reference) | USP Monograph / Ph. Eur. |
| Curcumin (Curcuma longa) | Rhizome | Curcuminoids (Curcumin, DMC, BDMC) | 95.0% Total Curcuminoids | HPLC / C-14 Radiocarbon | USP Dietary Supplement Compendium |
| Panax Ginseng (P. ginseng C.A. Mey.) | Root & Rootlet | Ginsenosides (Rg1, Re, Rb1, etc.) | 5.0% – 80.0% | HPLC / UV Confirmation | Ph. Eur. Monograph 1523 |
| Milk Thistle (Silybum marianum) | Ripened Achenes (Seeds) | Silymarin (calc. as Silybin) | 80.0% UV / 30.0%–50.0% HPLC | UV-Vis & HPLC Ph. Eur. | Ph. Eur. / DAB Monograph |
| Boswellia (Boswellia serrata) | Oleogum Resin | Boswellic Acids & AKBA | 65% Acids / 10%–30% AKBA | Titration / HPLC | Ph. Eur. Monograph 2310 |
Analytical assay parameters and specification limits can be adapted to specific customer finished product regulatory requirements across the UK, European Union, and North American jurisdictions.
The global botanical extracts ecosystem is undergoing fundamental shifts driven by consumer scrutiny, regulatory tightening, and novel food engineering. Procurement directors and product developers must navigate these core macro trends to ensure sustainable supply and consumer safety.
Formulators are moving away from chlorinated solvents and petrochemical hydrocarbons. The adoption of supercritical CO2, ultrasonic-assisted extraction, and subcritical water extraction processes preserves volatile phytochemicals while providing pristine zero-residual solvent profiles suited for clean-label nutraceuticals.
As botanical raw material values escalate, synthetic spiking—such as adding petrochemical curcumin to natural turmeric or synthetic theanine to tea extracts—has surged. Advanced buyers mandate Carbon-14 (C14) isotopic testing to verify natural biogenic origin alongside HPTLC fingerprinting.
Hydrophobic polyphenol molecules (such as curcumin, quercetin, and silymarin) suffer from poor intestinal absorption. Next-generation botanical extracts leverage liposomal encapsulation, cyclodextrin complexes, and self-microemulsifying drug delivery systems (SMEDDS) to yield 5x to 15x bioavailability improvements.
Global regulatory bodies continue to tighten thresholds for process-induced contaminants, particularly Polycyclic Aromatic Hydrocarbons (PAH4), ethylene oxide (EtO), and pyrrolizidine alkaloids (PA). Brands must procure botanical ingredients with documented trace-level contaminant testing to prevent costly market recalls.
With regulations like the EU Deforestation Regulation (EUDR) taking effect, global buyers require complete geographical polygon mapping and traceable supply networks. Sustainable wild-harvesting and audited cultivation ensure raw material supply resilience amidst shifting climatic conditions.
The consumer transition towards ready-to-drink (RTD) functional beverages and liquid dietary supplements requires fine-tuned organoleptic profiles. Spray-dried, micro-encapsulated extracts deliver instant clarity, neutral flavor impact, and stability against heat and pasteurisation cycles.
Nutraspect LLP bridges high-tier botanical extraction infrastructure with the stringent regulatory demands of global dietary supplement and pharmaceutical brands. Based in the United Kingdom, our scientific team brings decades of combined expertise in pharmacognosy, analytic chemistry, and international trade compliance.
Unlike conventional raw material distributors, Nutraspect eliminates operational variance through pre-shipment qualification, lot reservation, and rigorous secondary validation in ISO 17025 accredited laboratories. We treat the technical dossier as equally important as the ingredient itself.
Different delivery systems demand distinct physical properties. Our pharmaceutical-grade botanical extracts are tailored to achieve superior flowability, uniform active dispersal, and optimal thermodynamic stability across varied dosage formats.
Optimised bulk density (0.40–0.65 g/ml) and low moisture uptake prevent brittle shell degradation and machine gumming during high-volume encapsulation.
Granular particle sizes that ensure uniform die cavity filling, high compressibility indices, and low capping risk without excipient overload.
Instant water dispersibility, stable suspension properties, and pleasant neutral flavour profiles without gritty sedimentation.
Heat-stable extracts specifically manufactured to resist structural breakdown during pectin and gelatin boiling and moulding processes.
Ultra-low heavy metal and pesticide thresholds with high solubility in oil or water phases for luxury skincare and dermatological emulsions.
Standardised phytonutrient extracts calibrated for palatability, shelf stability, and targeted biological efficacy across pet companion nutrition.
Provide your target marker compounds, extraction solvents, and allowable excipient limits.
Receive representative pilot samples alongside matching analytical chromatography sheets.
Test dispersion, compressibility, and stability on your commercial machinery with QA sign-off.
Scheduled buffer-stock warehousing, validated cold-chain logistics, and consistent batch supply.
Direct communication with our technical sales team ensures rapid sample dispatch, detailed specification matching, and fast-track QA approval for your upcoming production cycles.
Include the following technical requirements for rapid turnaround:
Authoritative answers addressing questions commonly raised by procurement directors and quality assurance managers.
cGMP (Current Good Manufacturing Practice) certified botanical extracts are produced under strict operational controls audited by accredited regulatory bodies. Unlike generic industrial grades, GMP extracts require full operational qualification, validated cleaning protocols to eliminate cross-contamination, validated analytical quantification (typically HPLC or UHPLC), and complete batch manufacturing records (BMR) that guarantee full raw material traceability from botanical cultivation harvest to packaged extract drums.
Nutraspect implements a rigorous multi-tier testing protocol. We perform botanical identity verification via High-Performance Thin-Layer Chromatography (HPTLC) and DNA barcoding when required. To prevent synthetic spiking—common in high-value actives like curcumin or caffeine—we employ Carbon-14 (C14) radiocarbon testing to confirm 100% bio-based origin, supplemented by full chiral and HPLC profiling of natural phytochemical ratios.
Our extraction matrices strictly comply with ICH Q3C Guidelines for Residual Solvents and the European Pharmacopoeia (Ph. Eur. 5.4). Class 1 toxic solvents (such as benzene, 1,2-dichloroethane) are completely prohibited. We exclusively utilise clean Class 3 solvents (such as ethanol, water, or ethyl acetate) and eco-friendly supercritical CO2, with residual levels routinely verified by Headspace Gas Chromatography (GC-HS) to sit well below statutory limits.
Every CoA contains quantified batch test results conducted via ICP-MS for heavy metals: Lead (Pb) <= 0.5 ppm, Cadmium (Cd) <= 0.2 ppm, Arsenic (As) <= 0.5 ppm, and Mercury (Hg) <= 0.1 ppm, conforming to stringent California Proposition 65 and EU Regulation 2023/915 standards. Total Viable Aerobic Count (TAMC), Yeast and Mould (TYMC), Salmonella, E. coli, and Staphylococcus aureus are tested strictly per pharmacopeial standards.
Yes. Processing speeds on high-speed encapsulators and tableting presses demand precise physical powder characteristics. Nutraspect provides customised micronisation (80 mesh, 100 mesh, or 200 mesh), tapped/bulk density calibration, and clean excipient options (such as organic acacia fiber, maltodextrin, or carrier-free vacuum-dried powders) tailored to prevent machine gumming and capping.
For R&D testing and pilot-scale trials, qualifying commercial buyers can receive 50g to 200g laboratory samples along with batch-matched CoAs within 3 to 5 business days from our UK hub. Commercial production MOQs typically start at 25 kg (standard drums), with custom engineered batch standardisations available starting at 100 kg to 500 kg lots.